AbbVie Inc. is 47.9x more valuable than CYTOKINETICS INC by market capitalization ($399.47 B vs $8.35 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CYTK | ABBV |
|---|---|---|
| Market cap | $8.35 B | $399.47 B |
| US-listed rank | #1044 | #28 |
| Revenue (latest FY) | $88.04M | $61.16B |
| Net income (latest FY) | -$784.96M | $4.23B |
| Net margin | -891.6% | 6.9% |
| P/E (trailing FY) | - | 94.5 |
| SEC filings | 2,450 | 1,008 |
AbbVie Inc. is 47.9x more valuable than CYTOKINETICS INC by market capitalization ($399.47 B vs $8.35 B).
In their latest fiscal years, CYTOKINETICS INC reported $88.04M in revenue while AbbVie Inc. reported $61.16B.
Full pages: CYTOKINETICS INC and AbbVie Inc., or browse the full rankings.